GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Concord Biotech Ltd (NSE:CONCORDBIO) » Definitions » Loans Receivable

Concord Biotech (NSE:CONCORDBIO) Loans Receivable : ₹0 Mil (As of Dec. 2024)


View and export this data going back to 2023. Start your Free Trial

What is Concord Biotech Loans Receivable?

Concord Biotech's Loans Receivable for the quarter that ended in Dec. 2024 was ₹0 Mil.


Concord Biotech Loans Receivable Historical Data

The historical data trend for Concord Biotech's Loans Receivable can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Concord Biotech Loans Receivable Chart

Concord Biotech Annual Data
Trend Mar20 Mar21 Mar22 Mar23 Mar24
Loans Receivable
- - - - -

Concord Biotech Quarterly Data
Mar20 Mar21 Mar22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24
Loans Receivable Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Concord Biotech Loans Receivable Calculation

Loans Receivable are the funds that a company has lent but have not yet been repaid.


Concord Biotech Loans Receivable Related Terms

Thank you for viewing the detailed overview of Concord Biotech's Loans Receivable provided by GuruFocus.com. Please click on the following links to see related term pages.


Concord Biotech Business Description

Traded in Other Exchanges
Address
Iscon Cross Road, S.G. Highway, B-1601-1602, B-Wing, Mondeal Heights, Ahmedabad, GJ, IND, 380015
Concord Biotech Ltd is a research and development-driven biopharma company that manufactures Active Pharmaceutical Ingredients (API) through fermentation and semi-synthetic process and finished formulations. It is mainly engaged in the business of manufacturing and trading in pharmaceutical products.

Concord Biotech Headlines

No Headlines